相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual Drug Conjugated Nanoparticle for Simultaneous Targeting of Mitochondria and Nucleus in Cancer Cells
Abhik Mallick et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Self-Assembled Core-Shell Nanoparticles for Combined Chemotherapy and Photodynamic Therapy of Resistant Head and Neck Cancers
Chunbai He et al.
ACS NANO (2015)
Self-assembled nanoscale coordination polymers carrying siRNAs and cisplatin for effective treatment of resistant ovarian cancer
Chunbai He et al.
BIOMATERIALS (2015)
Oral delivery of a platinum anticancer drug using lipid assisted polymeric nanoparticles
Qinqin Cheng et al.
CHEMICAL COMMUNICATIONS (2015)
A Nanoparticle Cocktail: Temporal Release of Predefined Drug Combinations
Rakesh K. Pathak et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy
Joseph Della Rocca et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Evaluation of nanoparticle delivered cisplatin in beagles
Brittany Feldhaeusser et al.
NANOSCALE (2015)
Polymeric Micelle-Mediated Delivery of DNA-Targeting Organometallic Complexes for Resistant Ovarian Cancer Treatment
Xiaopin Duan et al.
SMALL (2015)
Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug
Miles A. Miller et al.
NATURE COMMUNICATIONS (2015)
Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects
Wantong Song et al.
ACTA BIOMATERIALIA (2014)
Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy
Shutao Guo et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Nanoscale Metal-Organic Frameworks for the Co-Delivery of Cisplatin and Pooled siRNAs to Enhance Therapeutic Efficacy in Drug-Resistant Ovarian Cancer Cells
Chunbai He et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Detouring of cisplatin to access mitochondrial genome for overcoming resistance
Sean Marrache et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapy
Demin Liu et al.
NATURE COMMUNICATIONS (2014)
Lipid-Coated Cisplatin Nanoparticles Induce Neighboring Effect and Exhibit Enhanced Anticancer Efficacy
Shutao Guo et al.
ACS NANO (2013)
Platinum Compounds: A Hope for Future Cancer Chemotherapy
Imran Ali et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
pH-Triggered Charge-Reversal Polypeptide Nanoparticles for Cisplatin Delivery: Preparation and In Vitro Evaluation
Yue Huang et al.
BIOMACROMOLECULES (2013)
Cellular uptake, antitumor response and tumor penetration of cisplatin-loaded milk protein nanoparticles
Xu Zhen et al.
BIOMATERIALS (2013)
A cross-linked polymeric micellar delivery system for cisplatin(IV) complex
Haiqin Song et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles
Shanthi Ganesh et al.
JOURNAL OF CONTROLLED RELEASE (2013)
One-Pot Synthesis of Mesoporous Silica Nanocarriers with Tunable Particle Sizes and Pendent Carboxylic Groups for Cisplatin Delivery
Jinlou Gu et al.
LANGMUIR (2013)
Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug
Xiaoyang Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Biodegradable Polysilsesquioxane Nanoparticles as Efficient Contrast Agents for Magnetic Resonance Imaging
Juan L. Vivero-Escoto et al.
SMALL (2013)
Lipid-coated nanoscale coordination polymers for targeted cisplatin delivery
Rachel C. Huxford-Phillips et al.
RSC ADVANCES (2013)
Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer
Shanthi Ganesh et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
Yuanzeng Min et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
A Poly(γ, L-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery
Yerong Xiong et al.
BIOMATERIALS (2012)
Cisplatin@US-tube carbon nanocapsules for enhanced chemotherapeutic delivery
Adem Guven et al.
BIOMATERIALS (2012)
A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance
Haihua Xiao et al.
BIOMATERIALS (2012)
Carbon nanotube bottles for incorporation, release and enhanced cytotoxic effect of cisplatin
Jian Li et al.
CARBON (2012)
Functionalized mesoporous silica materials for controlled drug delivery
Piaoping Yang et al.
CHEMICAL SOCIETY REVIEWS (2012)
Acid Degradable Cross-Linked Micelles for the Delivery of Cisplatin: A Comparison with Nondegradable Cross-Linker
Vien T. Huynh et al.
CHEMISTRY OF MATERIALS (2012)
Cisplatin-Tethered Gold Nanoparticles That Exhibit Enhanced Reproducibility, Drug Loading, and Stability: a Step Closer to Pharmaceutical Approval?
Gemma E. Craig et al.
INORGANIC CHEMISTRY (2012)
Cisplatin drug delivery using gold-coated iron oxide nanoparticles for enhanced tumour targeting with external magnetic fields
Amelia J. Wagstaff et al.
INORGANICA CHIMICA ACTA (2012)
Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin
Chia-Hui Lin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Methoxypoly(ethylene glycol)-block-Poly(L-glutamic acid)-Loaded Cisplatin and a Combination With iRGD for the Treatment of Non-Small-Cell Lung Cancers
Wantong Song et al.
MACROMOLECULAR BIOSCIENCE (2012)
Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin
Joan Comenge et al.
PLOS ONE (2012)
Lipoplatin Formulation Review Article
G. P. Stathopoulos et al.
JOURNAL OF DRUG DELIVERY (2012)
Nanoscale Metal-Organic Frameworks for Biomedical Imaging and Drug Delivery
Joseph Della Rocca et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Biodegradable polymer - cisplatin(IV) conjugate as a pro-drug of cisplatin(II)
Haihua Xiao et al.
BIOMATERIALS (2011)
A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours
R. Plummer et al.
BRITISH JOURNAL OF CANCER (2011)
Delivery of drugs and biomolecules using carbon nanotubes
Sandeep Kumar Vashist et al.
CARBON (2011)
Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: Synthesis, antitumor efficiency in vivo and penetration in tumors
Dan Ding et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin
Gordon J. Kirkpatrick et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2011)
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Polymer-Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery
Santosh Aryal et al.
ACS NANO (2010)
Mesoporous Silica Microparticles Enhance the Cytotoxicity of Anticancer Platinum Drugs
Zhimin Tao et al.
ACS NANO (2010)
Poly (γ, L-glutamic acid)-cisplatin bioconjugate exhibits potent antitumor activity with low toxicity: A comparative study with clinically used platinum derivatives
Zhen Feng et al.
CANCER SCIENCE (2010)
Gold nanorods for platinum based prodrug delivery
Yuanzeng Min et al.
CHEMICAL COMMUNICATIONS (2010)
Biodegradable polymeric nanoparticles based drug delivery systems
Avnesh Kumari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial J. Wheate et al.
DALTON TRANSACTIONS (2010)
Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation
Maja J. A. de Jonge et al.
EUROPEAN JOURNAL OF CANCER (2010)
Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice
Daniel Moreno et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro
Michaela L. Krieger et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells
M. Hirai et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Exploring the binding of Pt drugs to gold nanoparticles for controlled passive release of cisplatin
Joan Comenge et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Surface Modification-Complexation Strategy for Cisplatin Loading in Mesoporous Nanoparticles
Jinlou Gu et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2010)
Polymer-Caged Nanobins for Synergistic Cisplatin-Doxorubicin Combination Chemotherapy
Sang-Min Lee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer
N. Mylonakis et al.
LUNG CANCER (2010)
Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice
Ashwin A. Bhirde et al.
NANOMEDICINE (2010)
Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy
Abhimanyu S. Paraskar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
Nagesh Kolishetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo
Mark S. Cohen et al.
AMERICAN JOURNAL OF SURGERY (2009)
Multifunctional core-shell magnetic cisplatin nanocarriers
Benjamin Thierry et al.
CHEMICAL COMMUNICATIONS (2009)
In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles
George Mattheolabakis et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications
Venkata K. Yellepeddi et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
Teni Boulikas
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Lipoplatin ™ Monotherapy: A Phase II Trial of Second-Line Treatment of Metastatic Non-Small-Cell Lung Cancer
A. Ravaioli et al.
JOURNAL OF CHEMOTHERAPY (2009)
Anionic PAMAM dendrimers as drug delivery vehicles for transition metal-based anticancer drugs
Michelle J. Pisani et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Dumbbell-like Au-Fe3O4 Nanoparticles for Target-Specific Platin Delivery
Chenjie Xu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads
Shanta Dhar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications
Melanie Kettering et al.
PHYSICS IN MEDICINE AND BIOLOGY (2009)
Enhancement of In Vivo Anticancer Effects of Cisplatin by Incorporation Inside Single-Wall Carbon Nanohorns
Kumiko Ajima et al.
ACS NANO (2008)
Characterization of cisplatin cytotoxicity delivered from PLGA-systems
Daniel Moreno et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia
Melania Babincova et al.
IEEE TRANSACTIONS ON NANOBIOSCIENCE (2008)
Cisplatin-loaded Au-Au2S noparticles for potential cancer therapy:: Cytotoxicity, in vitro carcinogenicity, and cellular uptake
Lei Ren et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2008)
Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice
Jong-Ho Kim et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation
Young-Il Jeong et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate
Shuang Cai et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Nanoscale coordination polymers for platinum-based anticancer drug delivery
William J. Rieter et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device
Shanta Dhar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex
S. Cafaggi et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells
Evangelos C. Gryparis et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Preparation and cytotoxicity of cisplatin-containing liposomes
A. D. Carvalho Junior et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2007)
Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice
Alvaro D. C. Junior et al.
LIFE SCIENCES (2007)
Nanocapsules: A novel lipid formulation platform for platinum-based anti-cancer drugs
Irene H. L. Hamelers et al.
JOURNAL OF LIPOSOME RESEARCH (2007)
Poly(γ,L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice
Haifeng Ye et al.
BIOMATERIALS (2006)
A phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer
Tomislav Dragovich et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Three generations of α,γ-diaminobutyric acid modified poly(propyleneimine) dendrimers and their cisplatin-type platinum complexes
E. Bellis et al.
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS (2006)
Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer
S. C. White et al.
BRITISH JOURNAL OF CANCER (2006)
Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles
PS Xu et al.
BIOMACROMOLECULES (2006)
Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy
PS Xu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2006)
Polymeric micelles for drug delivery
S. R. Croy et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats
H Uchino et al.
BRITISH JOURNAL OF CANCER (2005)
Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine
J Sastry et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2005)
Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma
C Lu et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077B103) in a preclinical tumor model of melanoma
WC Zamboni et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Improved targeting of platinum chemotherapeutics: the antitumour activity of the HPMA copolymer platinum agent AP5280 in murine tumour models
X Lin et al.
EUROPEAN JOURNAL OF CANCER (2004)
A phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
Toxicity of platinum compounds
JT Hartmann et al.
EXPERT OPINION ON PHARMACOTHERAPY (2003)
Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer
H Iinuma et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties
K Avgoustakis et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin
JMM Terwogt et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity
KNJ Burger et al.
NATURE MEDICINE (2002)
HPMA copolymers platinates containing dicarboxylato ligands. Preparation, characterisation and in vitro and in vivo evaluation
E Gianasi et al.
JOURNAL OF DRUG TARGETING (2002)
Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system
N Nishiyama et al.
PHARMACEUTICAL RESEARCH (2001)
分享论文
